Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 85Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 13Rectal Neoplasms 10Colorectal Neoplasms 10Stomach Neoplasms 3Biliary Tract Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor 1Recurrence 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm Metastasis 1Microbiota 1Gallbladder Neoplasms 1Fruquintinib 1Elderly Metastatic Colorectal Cancer Patients 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Cholangiocarcinoma 1Breast Cancer Organoids 1Breast Cancer Metastatic 1Brain Neoplasms 1Ampullary Adenocarcinoma 1

Interventions

Surveys and Questionnaires 86Blood Specimen Collection 58Interviews as Topic 28Observation 15Data Collection 15Radiotherapy 12Watchful Waiting 11Magnetic Resonance Spectroscopy 11Hematologic Tests 11Exercise 11Drug Therapy 11Quality of Life 9Biopsy 8Specimen Handling 7Therapeutics 6Restraint, Physical 6Magnetic Resonance Imaging 6Focus Groups 6pembrolizumab 5Standard of Care 5Rivaroxaban 5Phlebotomy 5Nivolumab 5Lapatinib 5Immune Checkpoint Inhibitors 5atezolizumab 4apixaban 4Trastuzumab 4Patient Reported Outcome Measures 4Palliative Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasms × Capecitabine × Clear all
NCT02420509 2025-06-04

Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis

University of California, San Diego

Terminated
2 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡